Title
Refractive Error and Ocular Findings Among Infants and Young Children With Severe Problem Behavior and Developmental Disabilities
Date Issued
02 October 2018
Access level
open access
Resource Type
journal article
Author(s)
Publisher(s)
Taylor and Francis Inc.
Abstract
The prevalence of refractive error and ocular disorders among infants and young children with severe behavioral problems and developmental disorders is not well defined, particularly in developing countries. We performed a retrospective review of ophthalmic examinations performed during a National Institutes of Health–funded cohort study of very young children in Peru with behavioral problems and at risk for developmental disorders. Two-hundred twenty-two children between the ages of 0 and 4 years (mean 2.2 ± 0.9 years) were examined and 100 (45.0%) had an abnormal ocular exam. Overall, the prevalence of refractive error was 33.3%, nystagmus was 12.2%, and strabismus was 10.9%. Among children with Down syndrome, refractive error ranged from 46.2% at age 2 to 85.7% at age 4. Refractive error and ocular disorders are highly prevalent even at a young age in children with behavioral problems and developmental disorders. Much of the visual impairment in this population is treatable; early identification and intervention can have a lifelong positive impact on neurodevelopment.
Start page
251
End page
265
Volume
11
Issue
4
Language
English
OCDE Knowledge area
Oftalmología
Pediatría
Subjects
Scopus EID
2-s2.0-85050522089
Source
Journal of Mental Health Research in Intellectual Disabilities
ISSN of the container
19315864
Sponsor(s)
Supported by the Fogarty International Research Grant No. HD 060500; Fogarty International Center, U.S. National Institutes of Health [HD 060500].
A retrospective review of ophthalmic data collected on children enrolled in the National Institutes of Health (NIH)–Fogarty International Center study Early Prevention of Aberrant Behavior in Neurodevelopmental Disorders in Peru (Grant No. HD 060500) was conducted. Institutional Review Board (IRB) approval was granted by the respective Peruvian and American institutions associated with the project (Centro Ann Sullivan del Peru, University of Kansas, and Duke University).
Supported by the Fogarty International Research Grant No. HD 060500; Fogarty International Center, U.S. National Institutes of Health [HD 060500]. We would like to acknowledge Joseph Zunt MD, MPH for his mentorship of Dr. Sauer during his Fogarty Scholar program and his critical revision of the manuscript.
Sources of information:
Directorio de Producción Científica
Scopus